Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
In comparisons using selected vision screening tests, trained nurses and lay people were able to correctly identify up to 68 percent of children with at least one of the most prevalent vision disorders of childhood: amblyopia (lazy eye), strabismus...
Surprising results from a nationwide clinical trial show that many children age seven through 17 with amblyopia (lazy eye) may benefit from treatments that are more commonly used on younger children.
An important clinical trial, sponsored by the National Eye Institute(NEI), a part of the National Institutes of Health (NIH), has provided doctors with improved prognostic indicators and treatment options for retinopathy of prematurity.
Researchers have found that the three-year progression of myopia (nearsightedness) in a large group of ethnically diverse children who wore progressive addition lenses (PALs or no-line bifocals) was slightly less than that of children who wore single...
Atropine eye drops given once a day to treat amblyopia, or lazy eye, the most common cause of visual impairment in children, work as well as the standard treatment of patching one eye.
Two groups of researchers have found no association between nighttime light exposure during sleep in the first two years of life and the subsequent development of nearsightedness, or myopia.
Modest supplemental oxygen given to premature infants with moderate cases of retinopathy of prematurity (ROP), a potentially blinding eye disorder, may not significantly improve ROP, but definitely does not make it worse, according to researchers funded